Jiao Xu

Dr. Jiao Xu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
LCLing Chen
Ling Chen
QYQiaohong Yao
Qiaohong Yao
JCJie Chen
Jie Chen
YPYuxiang Peng
Yuxiang Peng
JXJiao Xu
Jiao Xu
QFQiang Fu
Qiang Fu
This study presents a novel optical biosensor for human serum albumin (HSA) detection utilizing a heterostructure that integrates topological edge states with graphene. The sensor achieves high-sensitivity detection through optical topological modes and enables dynamic system responsiveness via graphene’s tunable conductivity regulated by Fermi level modulation. Numerical results demonstrate that topological edge state excitation induces a sharp reflectance dip (depth >95%) at 195.5 THz in the optical communication band, exhibiting exceptional responsiveness to refractive index variations while maintaining stability against environmental interference through topological protection. Dynamic optimization is realized through electrostatic gating modulation of graphene’s Fermi energy and layer number, with additional sensitivity enhancements achieved via precise control of sensing layer thickness and refractive index. The integration of topological photonics with two-dimensional materials provides a versatile foundation for developing sensing-therapeutic systems that address current challenges in biomedical applications, demonstrating significant potential for integration with nanozyme-based diagnostic and therapeutic nanotechnology. The platform’s exceptional field enhancement and tunability could potentially augment the imaging sensitivity of nanozyme-based contrast agents, while its precise modulation capabilities may improve therapeutic efficiency through optimized catalytic activity. Furthermore, the robust topological protection mechanism offers enhanced stability crucial for clinical translation, addressing key limitations in current nanozyme technology including biocompatibility concerns and inconsistent catalytic performance. This integrated approach opens new possibilities for miniaturized, tunable, and interference-resistant biosensing systems with significant potential for multimodal synergistic applications in clinical diagnostics and environmental monitoring.

7 February 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
JXJiao Xu
Jiao Xu
XPXianmin Pan
Xianmin Pan
TJTang Jiao
Tang Jiao
XPXianghua Peng
Xianghua Peng
YPYuXiang Peng
YuXiang Peng
A switchable enhancement group delay in the terahertz band based on a novel sandwich topology protection structure with graphene is proposed in this paper. The notable phase transition of the reflected beam comes from the topological edge-protected mode excited at the sandwich photonic crystal surface, and the non-trivial topology of the photonic crystal allows the structure to be immune against defects and imperfections, which lays the foundation for the enhancement of group delay in the terahertz band. And the introduction of graphene creates favorable conditions for the reversible switching of positive and negative reflection group delay. Moreover, the reflected group delay can also be flexibly and dynamically controlled by the incident angle. The positive and negative reversible switching reflected group delay proposed in the terahertz band greatly reduces the optical transmission loss and significantly increases the transmission efficiency compared with the traditional metal sandwich structure, which provides a feasible idea for the realization of multi-dimensional manipulation of the wavelength and phase of electromagnetic waves in the terahertz band. The novel scheme is expected to provide potential applications in fields such as optical buffers or ultrafast modulators.

9 January 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
LCLing Chen
Ling Chen
QYQiaohong Yao
Qiaohong Yao
JCJie Chen
Jie Chen
YPYuxiang Peng
Yuxiang Peng
JXJiao Xu
Jiao Xu
QFQiang Fu
Qiang Fu
This study presents a tunable terahertz biosensor based on a hybrid architecture integrating bulk Dirac semimetal (BDS) with a photonic crystal for the label-free and highly sensitive detection of human serum albumin (HSA). The sensor exhibits a sharp Fano resonance resulting from the synergistic coupling between a defect mode and the BDS-mediated plasmonic response, with its resonance frequency being highly sensitive to variations in the refractive index of the sensing layer. Electric field simulations confirm significant field confinement and enhancement within the sensing region. The electrically tunable property of BDS allows dynamic reconfiguration of the sensor’s sensitivity by adjusting the Fermi level (0.1–0.4 eV), though at the expense of a reduced figure of merit (FOM) due to broader resonance peaks and increased loss, necessitating a balance in practical implementations. Structural parameter analysis reveals that sensitivity is inversely proportional to the sensing layer thickness and gradually decreases with increasing refractive index. The proposed biosensor achieves a reflection dip deeper than 99% near 1 THz, with an angular sensitivity of 247.5°/RIU for minute refractive index changes (Δn = 0.002), demonstrating high sensitivity and excellent electrical tunability. This platform demonstrates pioneering potential in integrating diagnostic-treatment nanotechnology. Due to the powerful local field enhancement generated by the BDS photonic crystal heterostructure, the imaging sensitivity of the contrast agent based on nanoenzymes has been significantly improved. Moreover, the profound local field enhancement and dynamic tunability of this platform suggest its potential for real-time monitoring and regulation of the catalytic efficiency of nanoenzymes, which could address a fundamental challenge in therapeutic applications. Combined with its inherent biocompatibility and strong detection capabilities, this framework proposes a viable pathway toward the clinical translation of nanoenzyme technology. Our work thus establishes a foundational platform that paves the way for future multifunctional theranostic systems capable of combining sensitive biomarker monitoring with enhanced therapeutic effects.